GUFICBIO Q1 FY27 results at a glance
GUFIC BIOSCIENCES LTD. Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹261 cr |
|---|
| Revenue YoY | +16.6% |
|---|
| Operating profit | ₹38.9 cr |
|---|
| Operating margin | 14.9% |
|---|
| Net profit | ₹22.31 cr |
|---|
| Net profit YoY | +70.7% |
|---|
| Net profit QoQ | +1.9% |
|---|
| Net margin | 8.6% |
|---|
| Basic EPS | ₹2.22 |
|---|
| TTM revenue | ₹981 cr |
|---|
| TTM net profit | ₹73.46 cr |
|---|
| TTM net margin | 7.5% |
|---|
GUFICBIO Q1 FY27 results: what the numbers say
GUFIC BIOSCIENCES LTD. (GUFICBIO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹261 cr and a net profit of ₹22.31 cr, translating into earnings per share of ₹2.22.
Compared with the same quarter a year earlier, revenue grew by +16.6% and net profit grew sharply by +70.7%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹38.9 cr, an operating margin of 14.9% versus 11.4% a year ago — a gain of 3.5 percentage points.
GUFICBIO quarter-wise results table
Net profit
₹22.31 cr
+70.7% YoY
Operating profit
₹38.9 cr
+52.1% YoY
GUFIC BIOSCIENCES LTD. (GUFICBIO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹261 cr | ₹38.9 cr | ₹22.31 cr | 14.9% | 8.6% | ₹2.22 | +70.7% | +1.9% |
| Q4 FY262026-03-31 | ₹252 cr | ₹39.56 cr | ₹21.9 cr | 15.7% | 8.7% | ₹2.18 | — | +76.2% |
| Q3 FY262025-12-31 | ₹231 cr | ₹25.29 cr | ₹12.42 cr | 10.9% | 5.4% | ₹1.24 | — | -26.2% |
| Q2 FY262025-09-30 | ₹237 cr | ₹30.07 cr | ₹16.82 cr | 12.7% | 7.1% | ₹1.68 | — | +28.7% |
| Q1 FY262025-06-30 | ₹224 cr | ₹25.58 cr | ₹13.07 cr | 11.4% | 5.8% | ₹1.30 | — | — |
| TTM (last 4 quarters) | ₹981 cr | ₹134 cr | ₹73.46 cr | 13.6% | 7.5% | ₹7.32 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
GUFICBIO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
GUFIC BIOSCIENCES LTD. quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹261 cr | ₹252 cr | ₹231 cr | ₹237 cr | ₹224 cr |
|---|
| Total expenses | ₹222 cr | ₹212 cr | ₹206 cr | ₹207 cr | ₹198 cr |
|---|
| Gross profit | ₹146 cr | ₹137 cr | ₹130 cr | ₹133 cr | ₹123 cr |
|---|
| Operating profit (EBIT) | ₹38.9 cr | ₹39.56 cr | ₹25.29 cr | ₹30.07 cr | ₹25.58 cr |
|---|
| Operating margin | 14.9% | 15.7% | 10.9% | 12.7% | 11.4% |
|---|
| Interest cost | ₹9.32 cr | ₹9.44 cr | ₹8.36 cr | ₹9.58 cr | ₹9.23 cr |
|---|
| Profit before tax | ₹30.04 cr | ₹28.95 cr | ₹17.72 cr | ₹22.6 cr | ₹17.27 cr |
|---|
| Tax expense | ₹7.73 cr | ₹7.05 cr | ₹5.3 cr | ₹5.78 cr | ₹4.2 cr |
|---|
| Effective tax rate | 25.7% | 24.4% | 29.9% | 25.6% | 24.3% |
|---|
| Net profit (PAT) | ₹22.31 cr | ₹21.9 cr | ₹12.42 cr | ₹16.82 cr | ₹13.07 cr |
|---|
| Net profit margin | 8.6% | 8.7% | 5.4% | 7.1% | 5.8% |
|---|
| Basic EPS | ₹2.22 | ₹2.18 | ₹1.24 | ₹1.68 | ₹1.30 |
|---|
| Diluted EPS | ₹2.22 | ₹2.18 | ₹1.24 | ₹1.68 | ₹1.30 |
|---|
GUFICBIO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +16.6% | — | — | — | — |
|---|
| Revenue QoQ | +3.6% | +8.8% | -2.4% | +6.0% | — |
|---|
| Operating profit YoY | +52.1% | — | — | — | — |
|---|
| Operating profit QoQ | -1.7% | +56.5% | -15.9% | +17.6% | — |
|---|
| Net profit YoY | +70.7% | — | — | — | — |
|---|
| Net profit QoQ | +1.9% | +76.2% | -26.2% | +28.7% | — |
|---|
| EPS YoY | +70.8% | — | — | — | — |
|---|
| EPS QoQ | +1.8% | +75.8% | -26.2% | +29.2% | — |
|---|
GUFICBIO annual results history
Full-year performance for GUFIC BIOSCIENCES LTD., useful for reading each quarter in context.
GUFIC BIOSCIENCES LTD. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹813 cr | ₹746 cr | ₹770 cr | ₹680 cr |
|---|
| Total expenses | ₹692 cr | ₹628 cr | ₹637 cr | ₹564 cr |
|---|
| Gross profit | ₹373 cr | ₹363 cr | ₹370 cr | ₹339 cr |
|---|
| Operating profit (EBIT) | ₹121 cr | ₹117 cr | ₹133 cr | ₹115 cr |
|---|
| Operating margin | 14.8% | 15.7% | 17.2% | 17.0% |
|---|
| Interest cost | ₹35.16 cr | ₹23.03 cr | ₹14.76 cr | ₹6.64 cr |
|---|
| Profit before tax | ₹86.55 cr | ₹94.14 cr | ₹116 cr | ₹107 cr |
|---|
| Tax expense | ₹22.34 cr | ₹24.49 cr | ₹29.54 cr | ₹27.02 cr |
|---|
| Effective tax rate | 25.8% | 26.0% | 25.5% | 25.3% |
|---|
| Net profit (PAT) | ₹64.21 cr | ₹69.65 cr | ₹86.14 cr | ₹79.7 cr |
|---|
| Net profit margin | 7.9% | 9.3% | 11.2% | 11.7% |
|---|
| Basic EPS | ₹6.40 | ₹6.95 | ₹8.74 | ₹8.22 |
|---|
| Diluted EPS | ₹6.40 | ₹6.95 | ₹8.74 | ₹8.22 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹261 cr against ₹224 cr in Q1 FY26, and ₹252 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +3.6%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹222 cr, or 85.1% of revenue, with operating profit grew +52.1% year on year.
Margins, tax and profitability
Net profit of ₹22.31 cr works out to a net margin of 8.6% compared with 5.8% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, GUFIC BIOSCIENCES LTD. reported profit before tax of ₹30.04 cr, a tax charge of ₹7.73 cr (effective rate 25.7%), interest cost of ₹9.32 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹21.9 cr in Q4 FY26 to ₹22.31 cr in Q1 FY27, a change of +1.9%.
Trailing twelve months and annual context
Across the trailing four quarters GUFIC BIOSCIENCES LTD. has generated revenue of ₹981 cr and net profit of ₹73.46 cr, a trailing net margin of 7.5%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹813 cr with net profit of ₹64.21 cr and EPS of ₹6.40, versus the prior year where revenue grew +9.0% and profit declined -7.8%.
What to watch in the next GUFICBIO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
GUFIC BIOSCIENCES LTD. has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
GUFICBIO results coverage
No results report published for GUFICBIO yet — our desk covers each quarter within minutes of the filing.
GUFICBIO quarterly results FAQs
What were GUFIC BIOSCIENCES LTD. (GUFICBIO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), GUFIC BIOSCIENCES LTD. reported revenue of ₹261 cr and net profit of ₹22.31 cr, a change of +70.7% year on year on +16.6% revenue growth. EPS stood at ₹2.22.
What is GUFICBIO profit margin in Q1 FY27?
GUFIC BIOSCIENCES LTD. posted a net profit margin of 8.6% and an operating margin of 14.9% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹981 cr and net profit ₹73.46 cr.
Did GUFICBIO results beat the previous quarter?
GUFIC BIOSCIENCES LTD. net profit changed +1.9% quarter on quarter, from ₹21.9 cr in Q4 FY26 to ₹22.31 cr in Q1 FY27.
When are GUFIC BIOSCIENCES LTD. (GUFICBIO) quarterly results?
GUFIC BIOSCIENCES LTD. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see GUFICBIO latest quarterly results?
Results coverage for GUFICBIO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the GUFICBIO stock page.
What is GUFIC BIOSCIENCES LTD. annual revenue and profit?
For FY26, GUFIC BIOSCIENCES LTD. reported full-year revenue of ₹813 cr and net profit of ₹64.21 cr, with EPS of ₹6.40.
How many quarterly results has GUFICBIO declared recently?
Past results dates for GUFICBIO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
